By Editorial Staff
December 01, 2025
In the landscape of modern patient advocacy, few organizations have managed to bridge the gap between medical necessity and emotional survival as effectively as Sharsheret. As the organization marks a poignant milestone—the tenth anniversary of the passing of its founder, Rochelle Shoretz—her sons, Shlomo and Dovid Mirsky, have issued a heartfelt call to action. Their appeal serves as both a remembrance of a visionary leader and a rallying cry for the thousands of families currently navigating the daunting terrain of breast and ovarian cancer.
The Genesis of a Movement: From Dining Room Table to Global Reach
The story of Sharsheret is one born from the intersection of personal tragedy and profound empathy. In 2001, when Rochelle Shoretz was diagnosed with breast cancer, the landscape of support for young, Jewish women facing such a diagnosis was virtually non-existent. At that time, cancer remained a deeply stigmatized subject within many communities.
Shlomo and Dovid, who were just three and five years old at the time of their mother’s initial diagnosis, recall a period defined by uncertainty. "Back then, cancer was a taboo subject," the brothers wrote in their recent appeal. "Initially, Mom struggled to find someone in a similar situation who could relate to her concerns about parenting, career, religion, and just Jewish life with cancer."
The pivotal moment occurred when Shoretz connected with Lauryn Weiser, a fellow young mother of three navigating a similar diagnosis. That singular connection illuminated a glaring void in the healthcare system: the need for peer-to-peer support tailored to the cultural and psychological nuances of Jewish families. What began as an informal support network—five women huddled around a dining room table—quickly evolved into a structured, international movement designed to ensure no woman ever had to face a cancer diagnosis alone.
A Decade Without the Founder: Reflecting on Milestones
Ten years have passed since Rochelle Shoretz lost her battle with cancer, yet the infrastructure she built has only grown more robust. Her sons reflect on the milestones she has missed—graduations, the birth of grandchildren, and the exponential expansion of the organization she founded.
However, the growth of Sharsheret is, in many ways, the ultimate tribute to her life’s work. The organization has transformed from a localized initiative into a powerhouse of psychosocial support, currently serving over 275,000 people annually. This growth demonstrates the enduring nature of Shoretz’s vision: that the specific needs of Jewish women, particularly those navigating the intersection of religion, family life, and cancer treatment, require specialized, culturally competent care.
Chronology: The Evolution of Sharsheret
- 2001: Rochelle Shoretz is diagnosed with breast cancer. Upon meeting Lauryn Weiser, the concept for Sharsheret is born.
- 2002: Sharsheret is formally established, focusing on peer support and resource navigation.
- 2005–2010: The organization expands its programming to include genetic counseling support, financial guidance, and mental health resources.
- 2015: The passing of founder Rochelle Shoretz. The organization commits to scaling its operations to honor her legacy.
- 2018–2022: Digital transformation allows Sharsheret to reach tens of thousands of women globally through virtual support groups and telehealth initiatives.
- 2025: Sharsheret reaches a milestone of assisting 275,000 individuals annually, solidifying its position as a global leader in oncology support.
The Human Element: Why Support Matters
While the data regarding Sharsheret’s reach is impressive, the true impact is found in the individual stories of families like the Mirskys. Shlomo and Dovid speak candidly about the "Busy Box" program—an initiative provided by Sharsheret that supplied age-appropriate distractions for young children while their mothers underwent chemotherapy or surgery.
"We were personally served by Sharsheret," the brothers noted. "Receiving Sharsheret’s Busy Box helped distract us from the difficult realities of Mom’s cancer treatments."
This is the essence of the organization’s philosophy: that cancer is a family diagnosis. By addressing the needs of children, spouses, and caregivers alongside the patient, Sharsheret mitigates the trauma that ripples outward from a medical diagnosis. The "Busy Box" is more than a toy kit; it is a symbol of normalcy in an abnormal time.
Supporting Data: The Scale of Need
As of late 2025, the demand for Sharsheret’s services has reached an all-time high. The organization’s impact is measured through a variety of vital metrics:
- Peer Support Network: Thousands of unique connections facilitated annually between newly diagnosed women and "peer supporters" who have successfully navigated similar treatment paths.
- Genetic Counseling: With the increased awareness of BRCA mutations within the Ashkenazi Jewish population, Sharsheret has become a primary resource for genetic education and hereditary risk assessment.
- Financial Assistance: Navigating the economic burden of cancer is a primary stressor for families; Sharsheret provides guidance on insurance, grants, and supplemental care funding.
- Community Outreach: Through partnerships with synagogues, community centers, and medical institutions, the organization works to destigmatize cancer screenings and promote early detection.
Official Responses and Implications for the Future
Health professionals and community leaders have frequently lauded Sharsheret for its clinical efficacy and compassionate delivery. Oncologists often refer patients to the organization not just for emotional support, but for the practical navigation of complex medical systems.
"The implication of Sharsheret’s work is a fundamental shift in how we approach cancer care," says Dr. Sarah Levinson, a leading oncology researcher. "By providing the psychological scaffolding that allows a patient to maintain their identity and their parenting role while undergoing treatment, they are effectively improving long-term health outcomes. Mental well-being is intrinsically linked to treatment adherence and recovery."
As the organization looks toward the next decade, the challenges remain significant. The rising cost of cancer care, the increasing complexity of genetic testing, and the need for personalized survivorship plans mean that Sharsheret’s mission is more vital than ever.
Call to Action: Ensuring the Legacy Continues
The year-end appeal from the Mirsky brothers is not merely a request for funding; it is an invitation to participate in a living legacy. The funds raised during the year-end campaign are earmarked for expanding current support programs and ensuring that the organization remains free of charge for every family that reaches out.
"Please join us in making a year-end donation to Sharsheret," the brothers urge. "We know that thanks to your generosity, Mom is looking down with pride as we build a healthier and brighter future for the next generation."
For donors, this represents an opportunity to invest in a proven model of care that has fundamentally changed the landscape of cancer support. By contributing to link.Sharsheret.org/EOY, supporters are helping to bridge the gap between diagnosis and recovery for thousands of women, ensuring that no mother, sister, or daughter has to walk the path of cancer in silence.
Conclusion
The legacy of Rochelle Shoretz is not captured in the buildings or the institutional growth of the organization she started; it is found in the voices of the 275,000 individuals who find hope, guidance, and a sense of community through Sharsheret each year.
As the world marks the ten-year anniversary of her passing, the call from Shlomo and Dovid Mirsky reminds us that while cancer may be a life-altering force, it does not have to be an isolating one. Through the collective action of a compassionate community, the work of Sharsheret continues to turn the tide, proving that when individuals come together to share the burden, they can create a future defined not by the limitations of illness, but by the strength of human connection.
About the Author
